Validation of the Johns Hopkins restless legs severity scale

Sleep Medicine
R P Allen, Christopher J Earley

Abstract

Determine reliability and validity of the Johns Hopkins restless legs severity scale (JHRLSS), an easily used clinical scale assessing severity of the restless legs syndrome (RLS). There is, prior to this study, no validated scale assessing the wide range of RLS severity. The JHRLSS has been used in prior studies to assess RLS severity, but has not previously been validated in relation to direct measures of the morbidity associated with RLS. A consecutive case series of 31 RLS patients was used in the study. The JHRLSS was validated by its correlation with objective measures by a polysomnogram of the sleep disturbances associated with RLS (periodic leg movements of sleep per hour (PLMS/h), and sleep efficiency). Reliability was determined from the independent ratings of two clinicians. Reliability measures for the JHRLSS based on inter-rater agreement were 0.91 (Spearman Rho) and 0.87 (Cramers V). The subjective JHRLSS correlated significantly with both objective measures of sleep: sleep efficiency (R=0.60, P<0.01) and PLMS/h (R=0.45, P=0.01). The JHRLSS provides a reliable, valid, easily used clinical assessment of RLS severity.

References

Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·A S Walters
Jan 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirP Lespérance
Apr 16, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirG Lavigne

❮ Previous
Next ❯

Citations

May 16, 2009·Journal of Neurology·Claudia TrenkwalderJuliane Winkelmann
Nov 1, 2011·Sleep & Breathing = Schlaf & Atmung·Paul YehJohn W Tsuang
Apr 3, 2003·Current Treatment Options in Neurology·Mark W. Mahowald
Jan 17, 2004·Sleep Medicine·John W Winkelman, Lindsay Johnston
Jan 17, 2004·Sleep Medicine·Diego Garcia-Borreguero
Nov 1, 2003·Sleep Medicine·Arthur S WaltersUNKNOWN International Restless Legs Syndrome Study Group
Nov 1, 2003·Sleep Medicine·Dipankar BhowmikSuresh C Dash
Jan 31, 2009·Nature Reviews. Drug Discovery·Jia JiaYu Zong Chen
Jun 10, 2010·Nature Reviews. Neurology·Claudia Trenkwalder, Walter Paulus
Jul 4, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·R P Allen, C J Earley
Feb 6, 2007·The Clinical Journal of Pain·Alison J BentleyDuncan Mitchell
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J W Winkelman
Nov 17, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·V E PearsonC J Earley
Oct 23, 2002·Drugs & Aging·Shawn A Milligan, Andrew L Chesson
Jul 29, 2008·Revue neurologique·E KarroumI Arnulf
Dec 26, 2008·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Raffaele FerriBirgit Högl
Dec 23, 2008·Journal of Neuroscience Methods·Esa RauhalaSari-Leena Himanen
May 22, 2007·Sleep Medicine·Mauro ManconiLuigi Ferini-Strambi
Nov 14, 2006·Sleep Medicine·Terry DeanChristopher J Earley
Jan 30, 2008·Pharmacotherapy·Robert Lee PageAndreas A Brieke
Jun 16, 2009·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Irene PichlerPeter P Pramstaller
Feb 7, 2006·The Journal of Laboratory and Clinical Medicine·Mark W Mahowald
Dec 3, 2011·Journal of Sleep Research·Jürgen FischerUNKNOWN Board of the European Sleep Research Society (ESRS), Regensburg, Germany
Apr 2, 2002·Expert Opinion on Investigational Drugs·Björn Wito Walther
May 17, 2015·Sleep Medicine·Subhashie Wijemanne, Joseph Jankovic
Dec 5, 2006·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Raffaele FerriLuigi Ferini-Strambi
Nov 28, 2012·Journal of Health Psychology·Maria José V VarelaGilmar F do Prado

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.